Holding(s) in Company
14/11/2023 08:30
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231114:nRSN3815Ta&default-theme=true
RNS Number : 3815T Dechra Pharmaceuticals PLC 14 November 2023
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB0009633180
Issuer Name
DECHRA PHARMACEUTICALS PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights; An acquisition or disposal of
financial instruments
3. Details of person subject to the notification obligation
Name
JPMorgan Chase & Co.
City of registered office (if applicable)
Country of registered office (if applicable)
US
4. Details of the shareholder
Name City of registered office Country of registered office
J.P. Morgan Securities plc
5. Date on which the threshold was crossed or reached
09-Nov-2023
6. Date on which Issuer notified
13-Nov-2023
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A) % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached 4.349485 3.354408 7.703893 8774131
Position of previous notification (if applicable) 2.394554 5.093863 7.488417
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible) Number of direct voting rights (DTR5.1) Number of indirect voting rights (DTR5.2.1) % of direct voting rights (DTR5.1) % of indirect voting rights (DTR5.2.1)
GB0009633180 4953698 4.349485
Sub Total 8.A 4953698 4.349485%
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument Expiration date Exercise/conversion period Number of voting rights that may be acquired if the instrument is % of voting rights
exercised/converted
Sub Total 8.B1
8B2. Financial Instruments with similar economic effect according to
(DTR5.3.1R.(1) (b))
Type of financial instrument Expiration date Exercise/conversion period Physical or cash settlement Number of voting rights % of voting rights
Cash-settled Equity Swap 20/02/2024 20/02/2024 Cash 6220 0.005452
Cash-settled Equity Swap 21/02/2024 21/02/2024 Cash 689000 0.604961
Cash-settled Equity Swap 04/03/2024 04/03/2024 Cash 5090 0.004469
Cash-settled Equity Swap 06/03/2024 06/03/2024 Cash 1420344 1.247101
Cash-settled Equity Swap 19/06/2024 19/06/2024 Cash 1526 0.001339
Cash-settled Equity Swap 27/06/2024 27/06/2024 Cash 1783 0.001565
Cash-settled Equity Swap 02/07/2024 02/07/2024 Cash 3066 0.002687
Cash-settled Equity Swap 12/07/2024 12/07/2024 Cash 1390089 1.220537
Cash-settled Equity Swap 31/07/2024 31/07/2024 Cash 39012 0.034252
Cash-settled Equity Swap 02/08/2024 02/08/2024 Cash 531 0.000462
Cash-settled Equity Swap 17/10/2024 17/10/2024 Cash 174549 0.153257
Cash-settled Equity Swap 04/11/2024 04/11/2024 Cash 17 0.000014
Cash-settled Equity Swap 07/11/2024 07/11/2024 Cash 4122 0.003619
Cash-settled Equity Swap 20/11/2024 20/11/2024 Cash 10374 0.009102
Cash-settled Equity Swap 03/12/2024 03/12/2024 Cash 45107 0.039602
Cash-settled Equity Swap 09/12/2024 09/12/2024 Cash 6000 0.005268
Cash-settled Equity Swap 16/01/2026 16/01/2026 Cash 420 0.000368
Cash-settled Equity Swap 10/06/2026 10/06/2026 Cash 9625 0.008451
Cash-settled Equity Swap 18/06/2027 18/06/2027 Cash 6891 0.006050
Cash-settled Equity Swap 30/05/2028 30/05/2028 Cash 6667 0.005852
Sub Total 8.B2 3820433 3.354408%
9. Information in relation to the person subject to the notification
obligation
2. Full chain of controlled undertakings through which the voting rights
and/or the financial instruments are effectively held starting with the
ultimate controlling natural person or legal entities (please add additional
rows as necessary)
Ultimate controlling person Name of controlled undertaking % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher Total of both if it equals or is higher than the notifiable threshold
than the notifiable threshold
JPMorgan Chase & Co. J.P. Morgan Securities plc 4.341025 3.354408 7.695433%
JPMorgan Chase & Co. J.P. Morgan Securities LLC
JPMorgan Chase & Co. J.P. Morgan SE
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
Chain of controlled undertakings:
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan Capital Holdings Limited (100%)
J.P. Morgan Securities plc (100%)
JPMorgan Chase & Co.
JPMorgan Chase Holdings LLC (100%)
J.P. Morgan Broker-Dealer Holdings Inc. (100%)
J.P. Morgan Securities LLC (100%)
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan SE (100%)
12. Date of Completion
13-Nov-2023
13. Place Of Completion
London
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END HOLUSUWROBUAARA